Our data did not suggest activation or proliferation of CD8+ T-cells, measured by HLA-DR and Ki67 expression, respectively28–30, either at baseline or following therapy in tumor or blood (Fig. 3e, f and Supplementary Fig. 5). The gene discussed is MKI67; the disease is neoplasm.